| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Total other income (expense), net | 1,800 | 2,134 | 88,234 | |
| Net (loss) income | -17,746 | -52,615 | 73,016 | |
| Unrealized loss on investments, net of tax | - | - | -15 | |
| Unrealized gain (loss) on investments, net of tax | 130 | 8 | - | |
| Comprehensive (loss) income | -17,616 | -52,607 | 73,001 | |
| Earnings per share, basic | -0.26 | -0.76 | 1.84 | |
| Earnings per share, diluted | -0.26 | -0.76 | 1.83 | |
| Weighted average number of shares outstanding, basic | 69,204,899 | 69,083,127 | 39,640,826 | |
| Weighted average number of shares outstanding, diluted | 69,204,899 | 69,083,127 | 39,932,539 | |
Whitehawk Therapeutics, Inc. (WHWK)
Whitehawk Therapeutics, Inc. (WHWK)